Author

H. L. Casellas Roman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. N. Zuniga· 1 shared A. Riva· 1 shared C. Gunaratne· 1 shared C. Jobin· 1 shared C. M. Berntsen· 1 shared D. Avram· 1 shared D. E. Shabashvili· 1 shared D. Kopinke· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. N. Zuniga

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer

Y. Feng, R. C. Newsome, T. Robinson, R. L. Bowman, A. N. Zuniga, K. N. Hall, C. M. Berntsen, D. E. Shabashvili, K. I. Krajcik, C. Gunaratne, Z. J. Zaroogian, K. Venugopal, H. L. Casellas Roman, R. L. Levine, W. K. Chatila, , O. A. Guryanova

This study shows that hematopoietic Dnmt3a haploinsufficiency worsens colitis-associated colon cancer by promoting angiogenesis, which can be targeted with axitinib.

bioRxiv · Dec 30, 2022 · PreprintCancer Biology